Tag: COPD
Panel of Biomarkers Can Distinguish Stable, Exacerbation States in COPD
Artificial neural network model can predict exacerbations at median of seven days before clinical diagnosis
Woman Receives World’s First Robotic Double-Lung Transplant
CHEST: Dupilumab for COPD Tied to Improvement in Health-Related Quality of Life
Symptoms and activity improved in patients with chronic obstructive pulmonary disease and type 2 inflammation
FDA Approves Dupixent for Chronic Obstructive Pulmonary Disease
Approval is the first in the U.S. for a biologic for the condition
Preclinical Blood Test IDs Risk for Respiratory Death, Incident COPD
Signature of respiratory susceptibility can identify individuals at risk for COPD, hospitalization from respiratory exacerbation, and death
People With Chronic Liver Disease Face More Barriers to Health Care
Findings tied to higher prevalence of socioeconomic vulnerabilities compared with those with chronic obstructive pulmonary disease or cardiovascular disease
Two-Thirds of COPD Hospitalized Patients Misuse Inhalers
Most misuse inhalers due to critical error in the inhalation technique
Race-Neutral Metrics More Accurately Predict Risk in COPD
GLI-Global differentiated all-cause mortality risk between normal spirometry and first grade of COPD in adjusted analyses
Pulmonologist Intervention Beneficial for Undiagnosed Asthma, COPD
Those receiving pulmonologist-directed treatment have less subsequent health care utilization for respiratory illness
Dupilumab Tied to Fewer Exacerbations in COPD With Type 2 Inflammation
Increase seen in prebronchodilator forced expiratory volume in one second with dupilumab versus placebo at weeks 12, 52
